Adobe Inc. (NASDAQ: ADBE) reported a 74% jump in earnings for the second quarter of 2020 driven by higher revenue. This came in the midst of the COVID-19 pandemic crisis.
Adobe announced that given the macroeconomic environment, it significantly accelerated in Q2 its previously stated strategy of eliminating low-margin Advertising Cloud transaction-driven offerings. The company will continue to offer its Advertising Cloud software solutions. The macroeconomic environment and this strategic shift impacted Advertising Cloud targeted revenue in Q2 by about $50 million.
Looking ahead into the third quarter, the company expects total revenue of about $3.15 billion, GAAP EPS of about $1.78, and non-GAAP EPS of about $2.40. Digital Media segment revenue is predicted to grow about 16% year-over-year while Digital Experience segment revenue is projected to remain flat year-over-year.
The outlook is factoring current macroeconomic conditions, continued impacts of the pandemic, typical Q3 summer seasonality, and its updated strategy for Advertising Cloud. In light of the macroeconomic environment and the strategic shifts for Advertising Cloud, Adobe is withdrawing the annual fiscal 2020 targets provided in December 2019.
Biotechnology company Monte Rosa Therapeutics is slated to go public this week. In a pandemic-ridden world, this industry is expanding at a healthy pace. The global biotechnology market is estimated
The healthcare sector is going through a phase of consolidation, creating fresh opportunities for emerging companies in a market that is slowly recovering from the pandemic. Several pharmaceuticals firms have
Shares of American Airlines Group (NASDAQ: AAL) have gained 42% since the beginning of this year and 50% over the past 12 months. Despite this, there is a mixed sentiment